The Nasal Sleep Stack Protocol — GABA, Melatonin, and DSIP Explained

Why Nasal Delivery Changes Everything About Melatonin Dosing

This is the part most people skip but it's the whole foundation of why a 100mcg nasal spray can compete with a 10mg pill.

When you swallow a melatonin pill it goes through your digestive tract, gets absorbed into the portal vein, and hits your liver before reaching your bloodstream. Your liver's CYP1A2 enzymes shred most of it. This is called first-pass metabolism and it's brutal for melatonin specifically.

DeMuro et al. (2000) measured oral melatonin bioavailability at about 15% in 12 healthy volunteers using 2mg and 4mg doses against an IV reference. [1] But Andersen et al. (2016) found it even worse — a median of just 2.5% using 10mg oral vs 10mg IV in 12 males. [2] The variation comes from dose-dependent saturation and individual differences in liver enzyme activity. Some people metabolize melatonin 25x faster than others.

So that 10mg pill? You're absorbing somewhere between 0.15mg and 1.5mg. The rest is getting destroyed. You're paying for 10mg and getting maybe a tenth of it.

Nasal delivery skips the liver entirely. The nasal mucosa is highly vascularized and drugs absorb directly into systemic circulation. In rabbits, Bechgaard et al. (1999) measured intranasal melatonin bioavailability at 55% without any absorption enhancers and 94% with them. [3] Time to peak was 5 minutes — the first blood draw they could take.

The only human PK data for intranasal melatonin comes from Helfrich et al. (2002) — 8 healthy males, 200–400mcg doses. [4] Absorption was so fast it couldn't be fitted to a standard pharmacokinetic model. The drug appeared in plasma before they could measure it.

No published study has directly compared intranasal vs oral melatonin bioavailability in humans using the gold-standard IV reference crossover design. That gap matters. But the pharmacokinetics from what we do have — 5 min nasal peak vs 41 min oral peak, 55–94% nasal bioavailability in animals vs 3–15% oral in humans — paint a pretty clear picture.

You're Taking 30–100x What Your Body Actually Makes

Here's a number that surprised me. Your pineal gland produces roughly 30 micrograms of melatonin per day. Not 0.3mg. Not 3mg. Thirty micrograms. A 10mg pill delivers 30–100x your body's entire daily output in one shot.

MIT's Zhdanova et al. (2001) ran the study that should have changed how everyone doses melatonin. 30 older adults, double-blind, placebo-controlled, three doses tested: 0.1mg, 0.3mg, and 3.0mg. [5] The 0.3mg dose — producing plasma levels in the normal nocturnal range — was just as effective as 3.0mg for sleep efficiency. The 3mg dose caused hypothermia and supraphysiological blood levels that persisted into morning.

A 2024 dose-response meta-analysis by Cruz-Sanabria et al. (26 RCTs, 1,689 observations) found peak efficacy around 4mg and confirmed that timing matters more than dose — taking melatonin 3 hours before bed beat taking it at bedtime regardless of the amount. [6]

What Happens When You Bomb Your Receptors

You have two melatonin receptor subtypes that matter for sleep. MT1 receptors promote sleep onset by reducing neuronal firing in the SCN. MT2 receptors handle circadian phase shifting.

Gerdin et al. (2003) showed that just 10 minutes of melatonin exposure reduced MT2 receptor binding by 70%. [7] At physiological concentrations, MT2 receptors desensitize but recover fully within 8 hours. At supraphysiological concentrations — what you get from megadose pills — recovery wasn't complete even after 24 hours. [8]

MT1 receptors are tougher. Physiological melatonin concentrations don't affect MT1 at all. Only supraphysiological doses desensitize them. So megadose pills hit both receptor subtypes while micro-doses leave MT1 completely intact and allow normal MT2 cycling.

That groggy zombie feeling in the morning? It's not just leftover melatonin in your blood. Your receptors are desensitized. The signal can't get through even when your body tries to regulate normally the next night. And you take another 10mg pill because last night "didn't work as well." Cycle continues.

The Quality Control Problem Nobody Talks About

Erland & Saxena (2017) tested 31 melatonin supplements across 16 brands. [9] Melatonin content ranged from −83% to +478% of what the label said. A chewable labeled at 1.5mg actually contained 9mg. Over 71% failed the ±10% label accuracy standard. 26% contained serotonin as a contaminant.

So you're taking an unknown dose of a compound you're already overdosing on, potentially contaminated with a neurotransmitter precursor.

Intranasal GABA — Plausible Mechanism, Almost Zero Evidence

GABA is the brain's primary inhibitory neurotransmitter. More GABA activity = calmer neurons = easier to fall asleep. Simple concept. The problem is getting it there.

Oral GABA supplements have been around forever. The traditional view is that GABA can't cross the blood-brain barrier well enough to matter. Kakee et al. (2001) measured this directly in rats and found the BBB actively pumps GABA out at a rate 16x higher than it lets it in. [10] Your brain does not want extra GABA showing up uninvited.

Boonstra et al. (2015) reviewed all the evidence and stated plainly: there have been no studies in humans that directly assessed GABA's BBB permeability. [11] Hepsomali et al. (2020) systematically reviewed 14 human trials of oral GABA supplements and found "very limited evidence" for sleep benefits. [12] Evidence quality was rated LOW to VERY LOW.

So why put GABA in a nasal spray?

The nose-to-brain pathway. Your nasal cavity has olfactory nerve bundles that project directly into the brain and trigeminal nerve branches that connect to the brainstem. Small molecules can theoretically travel along these nerves into the CNS without crossing the BBB at all. This pathway is established for other drugs — the FDA has approved intranasal esketamine and intranasal diazepam that exploit it.

For GABA specifically there is exactly one published study. Gladysheva et al. (1998) gave mice intranasal GABA at 0.5mg/kg and found behavioral effects (reduced aggression) lasting several days. [13] The same behavioral effect required 100mg/kg when injected systemically — 200x the dose. One mouse study. From 1998. In a Russian journal. No brain GABA concentrations were measured. No replication in 28 years.

Is 10mg intranasal a reasonable dose? Allometric scaling from the mouse effective dose suggests a human equivalent of about 2.8mg. So 10mg is in the right ballpark — maybe even generous. But no human has ever had their brain GABA levels measured after intranasal GABA administration. That's the honest state of the evidence.

DSIP — The Sleep Peptide With No Known Receptor

Delta Sleep Inducing Peptide was isolated in 1977 from electrically stimulated rabbit brains. It's a nonapeptide — nine amino acids — and its name implies it should be the holy grail of sleep compounds.

DSIP has no identified gene. No known receptor. No confirmed precursor protein. After 50 years of research, Kovalzon & Strekalova (2006) titled their review "DSIP: A Still Unresolved Riddle" and noted that the original isolation was performed once and never verified with modern methods. [14]

The human clinical data comes from one group — Schneider-Helmert in Basel. Between 1981–1987 they published four studies using IV DSIP at about 1,500mcg in groups of 6–14 chronic insomniacs. Results were positive. Independent replication failed. Monti et al. (1987) used the same dose and couldn't reach significance vs placebo. Bes et al. (1992) concluded it was "not likely to be of major therapeutic benefit."

This spray has 20mcg. 1/75th of the studied clinical dose. Through a route never tested for DSIP in humans. DSIP's plasma half-life is 7–8 minutes. The pharmacological argument at this dose is thin.

One interesting wrinkle: Ouichou et al. (1992) found DSIP stimulates melatonin production from rat pineal glands. [15] The mechanism appears to be that DSIP's degradation liberates its tryptophan residue which feeds into melatonin synthesis. A tryptophan delivery vehicle disguised as a neuropeptide. At 20mcg this is a trivial amount of tryptophan — but mechanistically it connects the dots between DSIP and melatonin in a way most write-ups miss.

The Protocol I Followed

I used the REM Spray from Adera State — pre-formulated nasal spray with GABA 10mg, melatonin 100mcg, and DSIP 20mcg per actuation. 100 sprays per bottle. Pre-dosed format eliminates reconstitution guesswork.

What Changed Over 14 Nights

What didn't change: Total sleep time stayed about the same. The spray made me sleep better, not longer.

Combination Synergy — Theoretical, Not Proven

Nobody has tested GABA + melatonin + DSIP together in any study. The theoretical framework works on paper — melatonin for circadian signaling, GABA for neuronal inhibition, DSIP for delta-wave architecture. Three mechanisms targeting three aspects of sleep.

Some pairwise data exists. Niles (1987) showed chronic melatonin increased GABA binding in rat brain. [17] Wang et al. (2003) found GABA-A receptor antagonists blocked melatonin's sleep effects in rats. [16] DSIP stimulates melatonin production in isolated rat pineal tissue.

The honest take: melatonin's micro-dosing science carries this stack. GABA has a plausible delivery advantage through the nose but near-zero evidence. DSIP at this dose is speculative. The combination is rational but untested.

Safety and Contraindications

Cycling: Probably not necessary at these doses. Long-term melatonin studies show maintained efficacy with no tolerance. But a 5-on/2-off pattern is reasonable if you want to be cautious.

The Takeaway

If you're taking 10mg melatonin pills you're probably overdosing by 20–30x and desensitizing the receptors that make melatonin work. Switching to a low-dose nasal delivery format addresses both problems — less drug, better absorption, faster onset, no morning fog.

Even if you never touch a nasal spray — drop your oral melatonin to 0.3–0.5mg taken 2–3 hours before bed. MIT says you'll sleep the same or better. Throw the 10mg pills away.

Studies Referenced